Oral Administration of Trifluoroacetyl Chitosan–Encapsulated Redshifted Immunofluorophore for NIR‐II Bioimaging of Colorectal Metastases
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202501877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yibing Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Key Laboratory of Lung Inflammation and Injury, Department of Pulmonary Medicine, …. Hauptthemen laut MEDLINE: Chitosan, Colorectal Neoplasms, Fluorescent Dyes. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Shanghai Municipal Science and Technology Major Project, Science and Technology Commission of Shanghai Municipality, Three-Year Action Plan for Strengthening the Construction of the Public Health System in Shanghai.
Abstract (Originalsprache)
The oral administration of immunofluorophores has been limited by gastrointestinal degradation. To address this, a novel immunofluorophore (ICGM‐B9‐FCS), based on a single‐domain antibody‐dye targeting the CEACAM5 antigen, is coated with trifluoromethyl chitosan (5 mg kg −1 ) for NIR‐II bioimaging of colorectal cancer and its distant metastases. ICGM‐B9‐FCS demonstrates unique advantages over existing intraoperative tumor‐guidance bioagents, including resistance to liver metabolism, well‐retained bioaffinity (EC 50 = 58.09 nmol L −1 ), enhanced relative quantum yield (up to 12 equivalents), significant redshifts in absorption (from 783 to 957 nm), effective oral delivery to colonic metastases, and in situ exploration of the capillary‐lymphatic network transportation. These findings establish a regulatory pathway for modifying immunofluorophores as orally administered bioagents, offering innovative methods for preoperative diagnosis and intraoperative guidance in colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Key Laboratory of Lung Inflammation and Injury, Department of Pulmonary Medicine, Zhongshan Hospital, Shanghai Engineering Research Center for Synthetic…
- Department of Chemistry, Fudan University, Shanghai, 200433, China.
- Key Laboratory of Organofluorine Chemistry, Shanghai Institute of Organic Chemistry, Shanghai, 200032, China.
- Children's Hospital, Fudan University, Shanghai, 201102, China.
- Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, Shanghai, 200032, China.
ORCID-Profile: Yibing Shi
Förderung
- Shanghai Municipal Science and Technology Major Project
- Science and Technology Commission of Shanghai Municipality
- Three-Year Action Plan for Strengthening the Construction of the Public Health System in Shanghai
- Key Technologies Research and Development Program
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Shi, Y., Zhu, X., Xu, Q., Wu, Y., Sun, Y., Zhao, X., Liu, Y., Feng, W., Xie, Y., Ying, T., & Yang, Z. (2026). Oral Administration of Trifluoroacetyl Chitosan–Encapsulated Redshifted Immunofluorophore for NIR‐II Bioimaging of Colorectal Metastases. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501877
Vancouver
Shi Y, Zhu X, Xu Q, Wu Y, Sun Y, Zhao X, et al. Oral Administration of Trifluoroacetyl Chitosan–Encapsulated Redshifted Immunofluorophore for NIR‐II Bioimaging of Colorectal Metastases. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202501877
BibTeX
@article{Shi2026,
author = {Shi, Yibing and Zhu, Xiaoyi and Xu, Qingyuan and Wu, Yanling and Sun, Yishuo and Zhao, Xin and Liu, Yulong and Feng, Wei and Xie, Youhua and Ying, Tianlei and Yang, Zhenlin},
title = {Oral Administration of Trifluoroacetyl Chitosan–Encapsulated Redshifted Immunofluorophore for NIR‐II Bioimaging of Colorectal Metastases},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202501877}
}
EUVIMED